Masih-Khan E - Search Results

1

Real-world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database.

Mian H, LeBlanc R, Louzada M, Masih-Khan E, McCurdy A, Venner CP, Stakiw J, Kardjadj M, Jimenez-Zepeda VH, Sebag M, White D, Aslam M, Song K, Reiman A, Kotb R, Gul E, Reece D. Mian H, et al. Among authors: masih khan e. Cancer Med. 2023 Feb;12(4):4357-4362. doi: 10.1002/cam4.5245. Epub 2022 Sep 26. Cancer Med. 2023. PMID: 36161712 Free PMC article.

2

Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13.

Reece D, Song KW, Fu T, Roland B, Chang H, Horsman DE, Mansoor A, Chen C, Masih-Khan E, Trieu Y, Bruyere H, Stewart DA, Bahlis NJ. Reece D, et al. Blood. 2009 Jul 16;114(3):522-5. doi: 10.1182/blood-2008-12-193458. Epub 2009 Mar 30. Blood. 2009. PMID: 19332768 Free article. Clinical Trial.

3

Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survival.

Jimenez-Zepeda VH, Mikhael J, Winter A, Franke N, Masih-Khan E, Trudel S, Chen C, Kukreti V, Reece DE. Jimenez-Zepeda VH, et al. Biol Blood Marrow Transplant. 2012 May;18(5):773-9. doi: 10.1016/j.bbmt.2011.10.044. Epub 2011 Nov 4. Biol Blood Marrow Transplant. 2012. PMID: 22062804 Free article.

4

Efficacy of thalidomide-based therapy following lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma.

Kukreti V, Masih-Khan E, Young T, Chu CM, Jiang H, Trudel S, Chen C, Jimenez-Zepeda V, Reece DE. Kukreti V, et al. Am J Hematol. 2013 Apr;88(4):337-8. doi: 10.1002/ajh.23394. Epub 2013 Mar 12. Am J Hematol. 2013. PMID: 23494911 Free article. No abstract available.

5

Central nervous system involvement with multiple myeloma: long term survival can be achieved with radiation, intrathecal chemotherapy, and immunomodulatory agents.

Chen CI, Masih-Khan E, Jiang H, Rabea A, Cserti-Gazdewich C, Jimenez-Zepeda VH, Chu CM, Kukreti V, Trudel S, Tiedemann R, Tsang R, Reece DE. Chen CI, et al. Br J Haematol. 2013 Aug;162(4):483-8. doi: 10.1111/bjh.12414. Epub 2013 Jun 15. Br J Haematol. 2013. PMID: 23772701 Free article.

6

Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

Sun HL, Atenafu EG, Yeboah E, Reece DE, Trudel S, Kukreti V, Masih-Khan E, Winter A, Chen C. Sun HL, et al. Leuk Lymphoma. 2015 Feb;56(2):407-14. doi: 10.3109/10428194.2014.915544. Epub 2014 Jul 7. Leuk Lymphoma. 2015. PMID: 24738975

7

Phase I-II trial of oral cyclophosphamide, prednisone and lenalidomide for the treatment of patients with relapsed and refractory multiple myeloma.

Reece DE, Masih-Khan E, Atenafu EG, Jimenez-Zepeda VH, Anglin P, Chen C, Kukreti V, Mikhael JR, Trudel S. Reece DE, et al. Br J Haematol. 2015 Jan;168(1):46-54. doi: 10.1111/bjh.13100. Epub 2014 Aug 22. Br J Haematol. 2015. PMID: 25146584 Free article. Clinical Trial.

8

Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.

St Bernard R, Chodirker L, Masih-Khan E, Jiang H, Franke N, Kukreti V, Tiedemann R, Trudel S, Reece D, Chen CI. St Bernard R, et al. Bone Marrow Transplant. 2015 Jan;50(1):95-9. doi: 10.1038/bmt.2014.226. Epub 2014 Oct 6. Bone Marrow Transplant. 2015. PMID: 25285800 Clinical Trial.

9

CyBorD induction therapy in clinical practice.

Areethamsirikul N, Masih-Khan E, Chu CM, Jimenez-Zepeda V, Reece DE, Trudel S, Kukreti V, Tiedemann R, Chen C. Areethamsirikul N, et al. Bone Marrow Transplant. 2015 Mar;50(3):375-9. doi: 10.1038/bmt.2014.288. Epub 2015 Jan 19. Bone Marrow Transplant. 2015. PMID: 25599165

10

Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple Myeloma.

Reece DE, Trieu Y, Masih-Khan E, Atenafu EG, Chen C, Prica A, Tiedemann R, Trudel S, Kukreti V. Reece DE, et al. Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):387-94. doi: 10.1016/j.clml.2016.04.012. Epub 2016 May 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27349765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page